GO:1903779 regulation of cardiac conduction

Regulation of cardiac conduction (GO:1903779) is a biological process that encompasses any molecular or cellular event that modulates the frequency, rate, or extent of electrical signal propagation through the heart. This process is essential for maintaining a rhythmic heartbeat and for adapting cardiac output to physiological demand. At the cellular level, cardiac conduction relies on specialized cardiomyocytes, gap junctions, and ion channels that together ensure rapid and coordinated electrical activation of the myocardium. Disruption of this regulation can lead to life-threatening arrhythmias and conduction disorders. Understanding the mechanisms that control cardiac conduction is therefore a central goal in cardiovascular research. Recent work has highlighted the importance of the nanoscale architecture of the intercalated disk, the specialized junctional structure that mechanically and electrically couples adjacent cardiomyocytes, in setting conduction velocity and stability. In addition, comparative studies in model organisms such as Drosophila have identified conserved regulators of heart rate, including the Fragile X Mental Retardation Protein (FMRP), demonstrating that fundamental mechanisms of cardiac conduction regulation are shared across species. These findings underscore the need for precise genetic tools to dissect the causal roles of specific genes in cardiac conduction. This article reviews the definition, mechanisms, key genes, disease links, and research methods for GO:1903779, with a focus on how CRISPR-based models can accelerate discovery.

According to the Gene Ontology, GO:1903779 (regulation of cardiac conduction) is defined as any process that modulates the frequency, rate or extent of cardiac conduction. In other words, it includes all molecular, cellular, and physiological events that adjust how fast, how often, or how effectively electrical impulses travel through the heart. This term is a biological process and does not have synonyms in the current ontology. It encompasses both positive and negative regulation, such as changes in gap junction coupling, ion channel activity, or structural remodeling of the intercalated disk that alter conduction velocity.

Regulation of cardiac conduction is fundamental to normal heart function and organismal survival. Even subtle changes in conduction velocity or heart rate can predispose to arrhythmias, heart failure, and sudden cardiac death. Because cardiac conduction is modulated by a complex interplay of structural, electrical, and molecular factors, understanding its regulation offers opportunities for therapeutic intervention. Moreover, conserved regulators such as FMRP in Drosophila provide insights into ancient mechanisms that control heart rhythm. Research on GO:1903779 is therefore critical for developing new strategies to prevent and treat cardiac rhythm disorders.

The following genes and proteins have been implicated in the regulation of cardiac conduction based on published literature.

Regulation of cardiac conduction is itself modulated by multiple layers of control. At the molecular level, conserved regulators such as FMRP can influence heart rate, as shown in Drosophila. At the structural level, the nanoscale organization of the intercalated disk, including gap junction size and distribution, directly sets conduction velocity and is subject to remodeling. These regulatory mechanisms ensure that cardiac conduction adapts to physiological demands while remaining robust against perturbations.

Disruption of cardiac conduction regulation leads to arrhythmias, including atrial fibrillation, ventricular tachycardia, and conduction blocks. Alterations in gap junction coupling and intercalated disk structure are key contributors.

Mutations in ion channel genes such as SCN5A, KCNQ1, and KCNH2 cause inherited arrhythmia syndromes like long QT syndrome and Brugada syndrome, which are characterized by abnormal cardiac conduction.

Mutations in desmosomal genes (e.g., PKP2, DSP, DSG2) lead to arrhythmogenic cardiomyopathy, a disease marked by fibrofatty replacement and conduction defects.

Studies in Drosophila have linked FMRP to heart rate regulation, suggesting that conserved molecular pathways may contribute to human cardiac conduction disorders.

Patch clamp and multielectrode array recordings measure action potential duration, conduction velocity, and arrhythmia inducibility in cardiomyocytes and tissue preparations.

Super-resolution and electron microscopy reveal nanoscale organization of gap junctions and mechanical junctions that regulate conduction.

RNA-seq and proteomics identify molecular changes in cardiac conduction regulators under physiological and pathological conditions.

CRISPR-based knockout, knock-in, and overexpression models in mice, zebrafish, Drosophila, and hiPSC-derived cardiomyocytes enable causal testing of candidate genes.

Researchers studying regulation of cardiac conduction-related genes often need to determine whether a candidate gene is causally involved in electrical coupling, conduction velocity, or arrhythmia susceptibility. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell and animal models, enabling rigorous functional interrogation of GO:1903779 regulators.

Regulation of cardiac conduction (GO:1903779) is a critical biological process that ensures coordinated electrical activity in the heart. Its dysregulation leads to arrhythmias and conduction disorders, making it a key area of cardiovascular research. Conserved regulators such as FMRP highlight the evolutionary importance of this process. Advances in CRISPR-based models and imaging technologies are accelerating the discovery of new mechanisms and therapeutic targets. EDITGENE offers comprehensive services to support these efforts.